News
COR
333.56
-1.80%
-6.12
Weekly Report: what happened at COR last week (1102-1106)?
Weekly Report · 6h ago
Cencora’s Q3 CY2026 earnings call: our top 5 analyst questions
Barchart · 3d ago
Cencora Price Target Raised to $405.00/Share From $388.00 by Leerink Partners
Dow Jones · 3d ago
Cencora Is Maintained at Outperform by Leerink Partners
Dow Jones · 3d ago
Cencora (COR) Gets a Buy from Leerink Partners
TipRanks · 4d ago
Cencora price target raised to $360 from $345 at BofA
TipRanks · 4d ago
Cencora Price Target Raised to $380.00/Share From $350.00 by Evercore ISI Group
Dow Jones · 4d ago
Cencora Is Maintained at Outperform by Evercore ISI Group
Dow Jones · 4d ago
Cencora price target raised to $405 from $375 at Baird
TipRanks · 4d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Eli Lilly & Co (LLY), Cencora (COR) and Revolution Medicines (RVMD)
TipRanks · 4d ago
Cencora Earnings Call Highlights Specialty Growth and Headwinds
TipRanks · 4d ago
Cencora Reports Revised Segment Information Following Operating Model Restructuring
TipRanks · 5d ago
Cencora raises dividend by 10% to $0.66
Seeking Alpha · 5d ago
Cencora reports new organizational and reporting structure
TipRanks · 5d ago
Cencora Raises Quarterly Dividend by 10%
Dow Jones · 5d ago
Cencora Reports Strong Fourth-Quarter Revenue and Earnings Growth
TipRanks · 5d ago
Cencora sees FY27 adjusted EPS $19.40-$19.75, consensus $19.76
TipRanks · 5d ago
Cencora reports Q4 adjusted EPS $4.66, consensus $4.57
TipRanks · 5d ago
Cencora raises quarterly dividend 10% to 66c from 60c per share
TipRanks · 5d ago
*Cencora Sees FY27 Capital Spending About $1B >COR
Dow Jones · 5d ago
More
Webull provides a variety of real-time COR stock news. You can receive the latest news about Cencora Inc. through multiple platforms. This information may help you make smarter investment decisions.
About COR
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.